Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T16:36:54.007Z.
Calculation as of: 2026-10-06T16:36:54.007Z.
Quote observation: 2026-10-06T16:34:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5ff4a69d5e0bd829addfa263bba904bf87580f902e4d2830b11cef9910c58a28
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$125.34M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.40M
Price/OCF Ratio
N/A
TTM Avg
66.43
3Y Avg
66.43
5Y Avg
66.43
Market Cap
$133.75M
Price/OCF Ratio
4.74
TTM Avg
39.51
3Y Avg
39.66
5Y Avg
39.66
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $126.43M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $125.34M | N/A | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB)vs › | $123.16M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.95M | N/A | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $121.75M | N/A | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $121.01M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $134.40M | N/A | 66.43 | 66.43 | 66.43 |
| Health Catalyst, Inc. (HCAT)vs › | $133.75M | 4.74 | 39.51 | 39.66 | 39.66 |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.22M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
